Venetoclax, Azacitidine, and Lintuzumab-Ac225 in AML Patients
Clinical trial NCT03932318 · WITHDRAWN
Trial details
- NCT number
- NCT03932318
- Sponsor
- Actinium Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2023-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.